Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-03T00:37:34.378Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Exposure to Parvovirus B19: Low Risk of Transmission to Healthcare Workers

Published online by Cambridge University Press:  02 January 2015

Susan M. Ray ,
Dean D. Erdman ,
Jeffrey D. Berschling ,
Joan E. Cooper ,
Thomas J. Török  and
Henry M. Blumberg
Susan M. Ray*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia Department of Epidemiology, Grady Memorial Hospital, Atlanta, Georgia
Dean D. Erdman
Affiliation:
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Jeffrey D. Berschling
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Joan E. Cooper
Affiliation:
Department of Epidemiology, Grady Memorial Hospital, Atlanta, Georgia
Thomas J. Török
Affiliation:
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Henry M. Blumberg
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia Department of Epidemiology, Grady Memorial Hospital, Atlanta, Georgia
*
Department of Medicine, Infectious Diseases, Emory University School of Medicine, 69 Butler St SE, Atlanta, GA 30303
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To evaluate the risk of nosocomial transmission of parvovirus B19 (B19) infection to healthcare workers (HCWs) exposed to patients with transient aplastic crisis (TAC) caused by acute B19 infection.

Design:

Cohort study.

Setting:

1,000-bed, urban teaching hospital in Atlanta, Georgia.

Participants:

Eighty-seven exposed HCWs who cared for two patients with TAC prior to the time they were isolated and a comparison group of 88 unexposed HCWs from wards or clinics where the patients did not receive care.

Intervention:

Self-administered questionnaire on hospital contact with index patients, B19 community risk factors, and signs and symptoms suggestive of B19 disease. Serology for B19-specific IgM and IgG antibodies measured by antibody-capture enzyme-linked immunosorbent assay.

Results:

1 (3.1%) of the 32 nonimmune exposed HCWs had serologic evidence of recent B19 infection compared to 3 (8.1%) of the 37 nonimmune HCWs in the comparison group (P=.6). In a subgroup analysis of exposed HCWs who cared for index patients during the time when the virus load was expected to be greatest, a recent infection rate of 5.8% (1/17) was found among nonimmune HCWs.

Conclusions:

The finding of similar rates of recent infection in nonimmune exposed and unexposed HCWs suggests that transmission to HCWs did not occur, despite failure to place the patients in isolation at the onset of hospitalization.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 18 , Issue 2 , February 1997 , pp. 109 - 114
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Török, TJ. Parvovirus B19 and human disease. Adv Intern Med 1992;37:431–455.Google Scholar
2. Brown, KE, Young, NS, Liu, JM. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994;16:1–31.CrossRefGoogle ScholarPubMed
3. Chorba, T, Coccia, P, Holman, RC. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986;154:383–393.CrossRefGoogle ScholarPubMed
4. Frickhofen, N, Abkowitz, JL, Safford, M, et al. Persistent B19 par-vovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926–933.CrossRefGoogle ScholarPubMed
5. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J 1990;300:1166–1170.Google Scholar
6. Török, TJ. Human parvovirus B19. In: Remington, JS, Klein, JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia, PA: W.B. Saunders; 1995:668–702.Google Scholar
7. Anderson, MJ, Higgins, PG, Davis, LR, et al. Experimental par-vovirus infection in humans. J Infect Dis 1985;152:257–265.CrossRefGoogle ScholarPubMed
8. Centers for Disease Control. Risks associated with human par-vovirus B19 infection. MMWR 1989;38:81-88,93–97.Google Scholar
9. Evans, JPM, Rossiter, MA, Kumaran, TO, Marsh, GW. Human parvovirus aplasia: case due to cross infection in a ward. Br Med J 1984;288:681.CrossRefGoogle ScholarPubMed
10. Bell, LM, Naides, SJ, Stoffman, P, Hodinka, RL, Plotkin, SA. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989;321:485–491.Google Scholar
11. Pillay, D, Patou, G, Hurt, S, Kibbler, CC, Griffiths, PD. Parvovirus B19 outbreak in a children's ward. Lancet 1992;339:107–109.CrossRefGoogle Scholar
12. Seng, C, Watkins, P, Morse, D, et al. Parvovirus B19 outbreak on an adult ward. Epidemiol Infect 1994;113:345–353.CrossRefGoogle Scholar
13. Shishiba, T, Matsunaga, Y. An outbreak of erythema infectiosum among hospital staff members including a patient with pleural fluid and pericardial effusion. J Am Acad Dermatol 1993;29:265–267.Google Scholar
14. Dowell, SF, Török, TJ, Thorp, JA, et al. Parvovirus B19 infection in hospital workers: community or hospital acquisition. J Infect Dis 1995;172:1076–1079.Google Scholar
15. Erdman, DD, Usher, MJ, Tsou, C, et al. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 1991;35:110–115.CrossRefGoogle ScholarPubMed
16. Kajigaya, S, Fujii, H, Field, A, et al. Self-assembled B19 par-vovirus capsids, produced in a baculovirus system, are anti-genically and immunologically similar to native virus. Proc Natl Acad Sci USA 1991;88:4646–4650.Google Scholar
17. Koziol, DE, Kurtzman, G, Ayub, J, Young, NS, Henderson, DK. Nosocomial human parvovirus B19 infection: lack of transmission from a chronically infected patient to hospital staff. Infect Control Hosp Epidemiol 1992;13:343–348.CrossRefGoogle ScholarPubMed
18. Frickhofen, N, Young, NS. Persistent parvovirus B19 infection in humans. Microb Pathog 1989;7:319–327.Google Scholar
19. Naides, SJ. Infection control measures for human parvovirus B19 in the hospital setting. Infect Control Hosp Epidemiol 1989;10:326–329.Google Scholar